FUNDACION PÚBLICA ANDALUZA PROGRESO Y SALUD;INSTITUTO DE SALUD CARLOS III
发明人:
Bernat Soria Escoms,Abdelkrim Hmadcha,Lourdes Acosta López,Natalia Escacena Acosta
申请号：
US14909190
公开号：
US20160161504A1
申请日:
2014.08.01
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention refers to the use of tissue type plasminogen activator (tPA) and/or plasminogen activator inhibitor (PAI-1) for prognosticating or predicting a thrombotic event associated to the treatment with MSCs of a human subject suffering from an inflammatory disease.
